AZN ASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 83.20 $ -0.66 (-0.79 %)    

Tuesday, 21-Oct-2025 15:59:57 EDT
QQQ $ 610.28 $ -0.12 (-0.02 %)
DIA $ 469.32 $ 2.06 (0.44 %)
SPY $ 670.78 $ -0.23 (-0.03 %)
TLT $ 91.99 $ 0.03 (0.03 %)
GLD $ 378.85 $ -8.85 (-2.29 %)
$ 83.87
$ 83.84
$ 83.11 x 10
$ 84.40 x 14
$ 83.12 - $ 83.89
$ 60.82 - $ 86.57
5,016,376
na
130.05B
$ 0.46
$ 7.18
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 the-european-agency-recommends-approving-astrazenecas-saphnelo-as-self-administered-once-weekly-pre-filled-pen-for-systemic-lupus-erythematosus-on-top-of-standard-therapy-8k

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on interi...

Core News & Articles

AstraZeneca and Daiichi Sankyo's DATROWAY also demonstrated a highly statistically significant and clinically meaningful 43...

Core News & Articles

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation

 invo-fertility-stock-is-plunging-after-white-house-announcement

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

 tropion-pantumor03-phase-2-trial-shows-that-datroway-jointly-developed-and-commercialized-by-daiichi-sankyo-and-astrazeneca-reveals-promising-tumor-responses-in-patients-with-metastatic-urothelial-cancer-in-tropion-pantumor03-phase-2-trial-a-confirmed-objective-response-rate-of-682-and-a-disease-control-rate-of-955-was-observed-in-previously-untreated-cisplatin-ineligible-patients

Initial results from one sub-study of the TROPION-PanTumor03 phase 2 trial showed that DATROWAY® (datopotamab deruxtecan) plus ...

 astrazeneca-shares-matterhorn-phase-iii-trial-results-for-patients-treated-with-neoadjuvant-imfinzi-in-combination-with-chemotherapy-before-surgery-followed-by-adjuvant-imfinzi-in-combination-with-chemotherapy-then-imfinzi-monotherapy

More than two thirds of patients treated with IMFINZI-based perioperative regimen were alive at three yearsFirst and only perio...

 uk-finance-minister-seeks-more-pharma-investment-in-exchange-for-higher-drug-prices-report

UK finance minister Rachel Reeves told reporters that the country needs to be an attractive place for pharma, including in term...

 mercks-keytruda-plus-chemo-regimen-shows-overall-survival-benefit-in-recurrent-ovarian-cancer-patients

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer...

Core News & Articles

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 ...

 hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

 astrazeneca-opens-expanded-manufacturing-facility-in-coppell-texas

AstraZeneca (NASDAQ:AZN) opened its expanded manufacturing facility in Coppell, Texas, following a $445 million investment to d...

 astrazeneca-advances-ambition-to-redefine-cancer-care-with-new-data-across-diverse-portfolio-and-pipeline-at-esmo-congress-october-17-21

Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab ...

 astrazeneca-ceo-soriot-says-negotiated-3-year-tariff-exemption-with-trump-administration

https://www.youtube.com/watch?v=XOtOCzut9pM

Core News & Articles

https://www.youtube.com/watch?v=XOtOCzut9pM

 president-trump-says-astrazeneca-will-offer-prescription-medications-to-medicaid-at-most-favored-nations-prices

https://www.youtube.com/watch?v=XOtOCzut9pM

Core News & Articles

https://www.youtube.com/watch?v=XOtOCzut9pM

 trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

 trump-strikes-drug-pricing-deal-with-pharma-giant-astrazeneca--msnbc

https://www.msnbc.com/msnbc/news/trump-strikes-drug-pricing-deal-pharma-giant-astrazeneca-rcna236905

 uk-weighs-25-rise-in-drug-prices-as-pharma-giants-pause-investments

UK ministers consider raising NHS drug spending by up to 25% amid pharma investment delays and pressure from US pricing policies.

 astrazeneca-expands-virginia-investment-to-45-billion-for-cancer-obesity-drugs

AstraZeneca will invest $4.5 billion in a Virginia facility, creating 3,600 jobs and producing advanced cancer and metabolic me...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION